Search results for " guidance" in Articles / App Notes
								 					Article
				
				Securing the Single-Use Supply Chain
								Many of the industry-wide initiatives already underway to provide standardization and guidance on change notification, leachable/extractable testing, and other end-user needs for increased adoption of…								
								 					Article
				
				Improving PAT for Biologics
								The software permits early detection of process deviations and provides user guidance for identifying potential root causes of these deviations by displaying easy-to-understand graphics, resulting in …								
								 					Article
				
				Application of Quality by Design to Viral Safety
								ICH Q5A, Note for Guidance on Quality of Biotechnological Products: Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Animal Origin, describes how the level of viral contami…								
								 					Article
				
				Applying GMPs to the BioPharma Supply Chain
								End users need to be equally open and clear to ensure that suppliers can provide their guidance as to the effective use of the raw material. 
	Effective (root cause) investigation approaches and too…								
								 					Article
				
				Defining Critical Quality Attributes for Monoclonal Antibody Therapeutic Products
								This is also consistent with guidance from regulators, who encourage firms to view attributes as lying along a “continuum of criticality,” in which attributes warrant different degrees of control depe…								
								 					Article
				
				FDA and EMA Extend QbD Parallel-Assessment Pilot Program
								The agencies have agreed that there are further QbD areas that warrant additional inter-agency harmonization and expect to publish more guidance documents in 2014.
	The program is open to applicatio…								
								 					Article
				
				Early Communication with Regulators is Essential for SMEs
								In the UK, an Innovation Office, opened in March by the country’s Medicines and Healthcare Products Regulatory Agency (MHRA), is providing multi-disciplinary guidance on “novel development methodologi…								
								 					Article
				
				2014 Manufacturing Trends and Outlook
								Reasons cited for not implementing QbD include a lack of guidance and direction from regulatory agencies (46.2%), no process or quality advantage to be gained (30.8%), a lack of understanding of the Q…								
								 					Article
				
				Supplier-Change Management for Drug-Product Manufacturers
								
	
	
	Pharmaceutical change management processes extend to the materials and services employed to manufacture and test drug products, necessitating the need for an effective supplier-initiated change …								
								 					Article
				
				State of Quality and Compliance in the Biopharmaceutical Industry
								The quality unit is needed to help assure the proper systems are in place, monitor those systems, and provide guidance when needed. To do this effectively, quality needs to have a presence on the shop…